-
Je něco špatně v tomto záznamu ?
Myxobacteria and their products: current trends and future perspectives in industrial applications
A. Shrivastava, RK. Sharma
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
- MeSH
- antibakteriální látky biosyntéza MeSH
- Myxococcales * chemie metabolismus MeSH
- průmyslová mikrobiologie * trendy MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Myxobacteria belong to a group of bacteria that are known for their well-developed communication system and synchronized or coordinated movement. This typical behavior of myxobacteria is mediated through secondary metabolites. They are capable of producing secondary metabolites belonging to several chemical classes with unique and wide spectrum of bioactivities. It is predominantly significant that myxobacteria specialize in mechanisms of action that are very rare with other producers. Most of the metabolites have been explored for their medical and pharmaceutical values while a lot of them are still unexplored. This review is an attempt to understand the role of potential metabolites produced by myxobacteria in different applications. Different myxobacterial metabolites have demonstrated antibacterial, antifungal, and antiviral properties along with cytotoxic activity against various cell lines. Beside their metabolites, these myxobacteria have also been discussed for better exploitation and implementation in different industrial sectors.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21028076
- 003
- CZ-PrNML
- 005
- 20211105134018.0
- 007
- ta
- 008
- 211105s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-021-00875-z $2 doi
- 035 __
- $a (PubMed)34060028
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Shrivastava, Akansha $u Department of Biosciences, Manipal University Jaipur, Rajasthan, 303007, Jaipur, India
- 245 10
- $a Myxobacteria and their products: current trends and future perspectives in industrial applications / $c A. Shrivastava, RK. Sharma
- 520 9_
- $a Myxobacteria belong to a group of bacteria that are known for their well-developed communication system and synchronized or coordinated movement. This typical behavior of myxobacteria is mediated through secondary metabolites. They are capable of producing secondary metabolites belonging to several chemical classes with unique and wide spectrum of bioactivities. It is predominantly significant that myxobacteria specialize in mechanisms of action that are very rare with other producers. Most of the metabolites have been explored for their medical and pharmaceutical values while a lot of them are still unexplored. This review is an attempt to understand the role of potential metabolites produced by myxobacteria in different applications. Different myxobacterial metabolites have demonstrated antibacterial, antifungal, and antiviral properties along with cytotoxic activity against various cell lines. Beside their metabolites, these myxobacteria have also been discussed for better exploitation and implementation in different industrial sectors.
- 650 _2
- $a antibakteriální látky $x biosyntéza $7 D000900
- 650 12
- $a průmyslová mikrobiologie $x trendy $7 D007218
- 650 12
- $a Myxococcales $x chemie $x metabolismus $7 D009231
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Sharma, Rakesh Kumar $u Department of Biosciences, Manipal University Jaipur, Rajasthan, 303007, Jaipur, India. rakeshkumar.sharma@jaipur.manipal.edu
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 66, č. 4 (2021), s. 483-507
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34060028 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211105 $b ABA008
- 991 __
- $a 20211105134023 $b ABA008
- 999 __
- $a ok $b bmc $g 1719454 $s 1148621
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 66 $c 4 $d 483-507 $e 20210531 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20211105